2025-2026 Regular Session • New York Legislature
A03833
Legislative Summary
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
Demographic Impact
Overall analysis of equity impact
95% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/30/2025
referred to insurance
Assembly
Status Information
Current Status
Introduced(1/30/2025)
Chamber
Assembly
Committee
Insurance(Assembly)
Sponsors
Democrat: 1
Primary Sponsor
David Weprin
Democrat